Gaps in glucagon fills among commercially insured patients receiving a glucagon prescription.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 16 03 2023
revised: 25 04 2023
accepted: 11 05 2023
pmc-release: 01 06 2024
medline: 6 6 2023
pubmed: 18 5 2023
entrez: 17 5 2023
Statut: ppublish

Résumé

Glucagon is critically underutilized, and we explored whether this is due to inadequate glucagon prescribing or the patient's inability to fill prescriptions. Of 216 commercially insured, high-risk individuals with diabetes who were prescribed glucagon in our healthcare system, 142 (65.4%) had a claim indicating its fill within 30 days.

Identifiants

pubmed: 37196705
pii: S0168-8227(23)00483-7
doi: 10.1016/j.diabres.2023.110720
pmc: PMC10278149
mid: NIHMS1904094
pii:
doi:

Substances chimiques

Glucagon 9007-92-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110720

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK114497
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: In the last 36 months, Dr. McCoy has received support from NIDDK, National Institute on Aging (NIA) of the NIH, Patient Centered Outcomes Research Institute (PCORI), National Center for Advancing Translational Sciences (NCATS), and AARP® for unrelated work. She also served as a consultant to Emmi® (Wolters Kluwer) on developing patient education materials related to diabetes.

Références

Diabetol Metab Syndr. 2022 Dec 23;14(1):193
pubmed: 36550552
Diabetes Care. 2023 Mar 1;46(3):620-627
pubmed: 36630526
J Diabetes Complications. 2021 May;35(5):107882
pubmed: 33593689
JAMA Netw Open. 2022 Aug 1;5(8):e2229428
pubmed: 36040744
JAMA Intern Med. 2021 Oct 1;181(10):1412-1414
pubmed: 34228043
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110
pubmed: 36507646
Endocr Pract. 2016 Feb;22(2):123-35
pubmed: 26484405
Diabet Med. 2023 Jun;40(6):e15084
pubmed: 36924085
Endocrine. 2019 May;64(2):233-238
pubmed: 30367442

Auteurs

Joseph R Herges (JR)

Department of Pharmacy, Mayo Clinic, Rochester, MN, United States. Electronic address: Herges.Joseph@mayo.edu.

Jordan D Haag (JD)

Department of Pharmacy, Mayo Clinic, Rochester, MN, United States. Electronic address: Haag.Jordan@mayo.edu.

Kimberly A Kosloski-Tarpenning (KA)

Department of Pharmacy, Mayo Clinic Health System, Southeast Minnesota Region, Owatonna, MN, United States. Electronic address: Tarpenning.Kimberly@mayo.edu.

Kristin C Mara (KC)

Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States. Electronic address: Mara.Kristin@mayo.edu.

Rozalina G McCoy (RG)

Division of Community Internal Medicine, Geriatrics, and Palliative Care, Mayo Clinic, Rochester, MN, United States. Electronic address: McCoy.Rozalina@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH